TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | -8 | -28 | -39 | 0 | 0 | -18 |
| P | %wins | 100 | 0 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/9/21 19:56 | 2/5/21 | LABP | Landos Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Poukalov Konstantin | VA | DT | P.m | 3,212 | 12.84 | 0 | 250 | 2 | 14,870 | I | |||||||||||||||
2/8/21 18:08 | 2/8/21 | LABP | Landos Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Poukalov Konstantin | VA | DT | P.d | 20,000 | 16.00 | 0 | 1,250 | 9 | 14,620 | I | |||||||||||||||
11/14/16 08:41 | 11/11/16 | KDMN | Kadmon Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Poukalov Konstantin | NY | O | EVP,CFO | P | 23 | 5.81 | 0 | 4 | New | 4 | D | -36 | -11 | 3 | 46 | 40 | 2 | -8 | -28 | -39 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |